Koblenz

EQS-News: Plan Optik AG: Preliminary figures for 2022 - Upper end of forecast reached

Retrieved on: 
Friday, March 24, 2023

On the earnings side, preliminary figures show a near doubling of EBIT to EUR 2.1 million (2021: EUR 1.1 million).

Key Points: 
  • On the earnings side, preliminary figures show a near doubling of EBIT to EUR 2.1 million (2021: EUR 1.1 million).
  • The growth achieved in the financial year 2022 was driven in particular by sustained demand from the microfluidics sector.
  • As early as 2022, Plan Optik AG had started with a comprehensive stocktaking including the identification of the right benchmarks.
  • Plan Optik AG will publish the detailed annual report for 2022 with the audited figures and a forecast for the current financial year at the end of April.

DGAP-News: CompuGroup Medical strengthens Management Board for sustainable growth

Retrieved on: 
Tuesday, February 15, 2022

Emanuele Mugnani promoted to the Board as Managing Director for Ambulatory Information Systems Europe, continuing the growth story

Key Points: 
  • Emanuele Mugnani promoted to the Board as Managing Director for Ambulatory Information Systems Europe, continuing the growth story
    Koblenz.
  • CompuGroup Medical (CGM), one of the leading e-health providers worldwide, is strengthening its Management Board.
  • About CompuGroup Medical SE & Co. KGaA
    CompuGroup Medical is one of the leading e-health companies in the world.
  • With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals.

DGAP-News: CGM confirms guidance after strong third quarter

Retrieved on: 
Thursday, November 4, 2021

CompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health providers in the world, is looking back on a successful third quarter.

Key Points: 
  • CompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health providers in the world, is looking back on a successful third quarter.
  • Michael Rauch, CFO of CompuGroup Medical, added, "We are pleased with the third quarter results: As expected, organic growth in the AIS segment is picking up and the CHS segment recorded a strong quarter.
  • With group revenues increasing by 19 % to EUR 276 million (previous year: EUR 231 million), CGM recorded a strong third quarter.
  • Organic growth in the third quarter was 5 %, mostly driven by a strong performance in the German and Spanish clinical business.

DGAP-News: Stabilus issues its first promissory note (Schuldschein) in the amount of EUR 95 million

Retrieved on: 
Thursday, March 4, 2021

Luxembourg/Koblenz, March 4, 2021 - Stabilus GmbH in Koblenz has issued a promissory note (Schuldschein) with a volume of EUR 95 million guaranteed by Stabilus S.A. in Luxemburg (ISIN: LU1066226637).

Key Points: 
  • Luxembourg/Koblenz, March 4, 2021 - Stabilus GmbH in Koblenz has issued a promissory note (Schuldschein) with a volume of EUR 95 million guaranteed by Stabilus S.A. in Luxemburg (ISIN: LU1066226637).
  • The issue was heavily oversubscribed, which enabled the Group to significantly increase the total volume compared to the initially planned EUR 50 million.
  • Mark Wilhelms, CFO of Stabilus S.A., said: "We are pleased with Stabilus' successful Schuldschein debut on the capital market.
  • The issue of the promissory note (Schuldschein) furthermore provides financial certainty for the period after the end of maturity of main existing loans in 2023.

DGAP-News: Stabilus S.A.: Annual General Meeting approves a dividend of EUR 0.50 per share

Retrieved on: 
Wednesday, February 10, 2021

Gas springs, dampers and electromechanical POWERISE drives from Stabilus optimize opening, closing, lifting, lowering and adjusting operations, and also protect against vibrations.

Key Points: 
  • Gas springs, dampers and electromechanical POWERISE drives from Stabilus optimize opening, closing, lifting, lowering and adjusting operations, and also protect against vibrations.
  • Employing a workforce of more than six thousand worldwide, the company has its operational headquarters in Koblenz.
  • Stabilus has reported sales revenues of EUR 822.1 million in the 2020 fiscal year.
  • This press release may contain forward-looking statements based on current assumptions and forecasts made by Stabilus Group management and other information currently available to Stabilus.